https://peptide.global/story/united-laboratories-semaglutide-nmpa-weight-filingPeptide Globalen2026-11-05T05:48:00.000ZChina NMPA accepts United Laboratories semaglutide filing for weight loss https://peptide.global/story/mounjaro-india-sales-overtake-augmentinPeptide Globalen2026-11-05T05:15:00.000ZMounjaro India sales overtake Augmentin as generic semaglutide volumes jump https://peptide.global/story/stevanato-glp-1-revenue-one-customerPeptide Globalen2026-11-05T04:51:00.000ZStevanato GLP 1 revenue expected to fall in 2027 with one customer behind the drop https://peptide.global/story/hanmi-efocipegtrutide-patent-lung-damagePeptide Globalen2026-11-05T04:05:00.000ZHanmi efocipegtrutide patent in the US aims a liver drug at lung damage https://peptide.global/story/shilpa-cdmo-peptide-investment-raichurPeptide Globalen2026-11-04T05:29:00.000ZShilpa CDMO peptide investment puts a first commercial line in Raichur by December